Wordt geladen...
Understanding the molecular basis of acute myeloid leukemias: where are we now?
Although the treatment modalities for acute myeloid leukemia (AML) have not changed much over the past 40 years, distinct progress has been made in deciphering the basic biology underlying the pathogenesis of this group of hematological disorders. Studies show that AML development is a multicause, m...
Bewaard in:
| Gepubliceerd in: | Int J Hematol Oncol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Future Medicine Ltd
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6172002/ https://ncbi.nlm.nih.gov/pubmed/30302223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/ijh-2017-0002 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|